trending Market Intelligence /marketintelligence/en/news-insights/trending/yxRy75LAEmDNbdZhnO5rGQ2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Suda Pharmaceuticals to raise A$3.4M in rights offering


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

Suda Pharmaceuticals to raise A$3.4M in rights offering

Suda Pharmaceuticals Ltd. is looking to raise up to A$3.4 million in a rights offering.

The Osborne Park, Western Australia-based drug delivery company is offering renounceable rights issue on a one for three basis, priced at 0.4 Australian cents per fully paid ordinary share.

Each two new shares subscribed under the transaction will come with one listed option exercisable for 1.5 Australian cents apiece until June 30, 2021.

Suda Pharmaceuticals will use the proceeds to strengthen its balance sheet, fund project development and address general working capital requirements.

The acceptance of offers will close June 21.